Table 2 Demographic characteristics of individuals with WSK-V102D booster

From: Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages

50 adults received a dose of WSK-V102D booster in October 2023

Age

Average age

41.6 (±16.6)

18-59 years n (%)

36 (72.00%)

≥ 60 years n (%)

14 (28.00%)

Gender

Male n (%)

15 (30.00%)

Female n (%)

35 (70.00%)

Number of previous COVID-19 vaccinations before WSK-102D

0-3 doses n (%)

20 (40.00%)

4-6 doses n (%)

30 (60.00%)

WSK-V102C booster

Yes n (%)

32 (64.00%)

No n (%)

18 (36.00%)

Heterologous boost

Yes n (%)

50 (100.00%)

No n (%)

0

Infection history

Yes n (%)

23 (46.00%)

No n (%)

27 (54.00%)